Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1192 participants.

Also called NCT07338175

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,192 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07338175
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07338175. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-02 (actual); primary completion 2028-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage
Acronym
MISTICH
Condition
Intracerebral Hemorrhage
Intervention (Drug)
Minocycline hydrochloride capsules
Intervention (Drug)
Placebo capsules of Minocycline hydrochloride capsules
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct07338175
Content hash
0df560fc0fe27ac415f5e6260b69ce6b38a7de5464ba909545accde9885ef930